Ovarian conservation for young women with clinical stage IB?IIB cervical cancer in Japan

Journal of Gynecologic Oncology 2017³â 28±Ç 4È£ p.19 ~ p.19

(Matsuo Koji) - University of Southern California Los Angeles County Medical Center Department of Obstetrics and Gynecology
(Shimada Muneaki) - Tottori University School of Medicine Department of Obstetrics and Gynecology
(Mikami Mikio) - Tokai University School of Medicine Department of Obstetrics and Gynecology

Abstract

Å°¿öµå

Correspondence
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
This study found that women younger than 50 years with clinical stage IB–IIB cervical cancer rarely undergo ovarian conservation at the time of radical hysterectomy in Japan. This finding is clearly different from what has shown in the US population where the ovarian conservation rates for stage IB disease showed nearly 30-fold higher.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå